Tenecteplase versus alteplase in patients with acute ischemic stroke: an updated systematic review and meta-analysis

Tenecteplase versus alteplase in patients with acute ischemic stroke: an updated systematic review and meta-analysis

Abstract Background Stroke was the second leading cause of death and the third leading cause of disability worldwide in 2019. Alteplase is an FDA-approved medication for the treatment of patients with ischemic stroke within 4.5 h. However, Tenecteplase is an alternative. We aimed to assess the safet...

Full description

Saved in:
Bibliographic Details
Main Authors: Abdelmonam M. Hagag, Muhammed E. Kormod, Mahmoud Elmwafy Ads, Mennatullah A. El-Refaay, Omnia M. Abozaid, Omar A. Ghanem, Mazen Yasser, Karim M. Abdelmoaty, Alaa Mahmoud Khedr, Gregory W. Albers
Format: Article
Language:English
Published: BMC 2025-08-01
Series:European Journal of Medical Research
Subjects:
Tenecteplase
Alteplase
Acute ischemic stroke
TNK
RtPA
Online Access:https://doi.org/10.1186/s40001-025-02983-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s40001-025-02983-9

Similar Items